Inventor
BUSCHMANN NICOLE
CH12 patents
⚠️ This page may combine multiple inventors who share the name “BUSCHMANN NICOLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BUSCHMANN NICOLE
6 patentsUS9266883B2Feb 23, 2016
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE16 citations90
US9533988B2Jan 3, 2017
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE13 citations82
US9896449B2Feb 20, 2018
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE2 citations71
US9802917B2Oct 31, 2017
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
BUSCHMANN NICOLE2 citations70
US10189813B2Jan 29, 2019
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE0 citations51
US8859535B2Oct 14, 2014
Hydroxy substituted isoquinolinone derivatives
BUSCHMANN NICOLE0 citations40
NOVARTIS AG
5 patentsUS10130629B2Nov 20, 2018
Pharmaceutical combinations
NOVARTIS AG3 citations71
US8053457B2Nov 8, 2011
3-imidazolyl-indoles for the treatment of proliferative diseases
NOVARTIS AG3 citations57
US10786492B2Sep 29, 2020
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations51
US10507201B2Dec 17, 2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations49
US9051279B2Jun 9, 2015
Substituted isoquinolinones and quinazolinones
NOVARTIS AG1 citations49